Feature image from PHARMAFILE
I have recently become aware of a clinical trial that has started in my nation’s capital, Canberra. That’s in Australia for anyone who didn’t know.
They said it has been studied as part of a treatment for ITP. My ears pricked up. How long has this been going on? I have started to search around online and have found a lot of information, not only about the trials and treatments for ITP using this drug Rituximab, but also the drug itself.
Articles – There is a lot of information, none of which I will try and summarise it all for you. It is far too important for that… Instead, I have linked a few articles that you might like to read. Most of them are over a year old already.
1. American Society of Hematology, Rituximab promotes long term response for ITP.
2. There is also an information sheet about the drug available from the Platelet Disorder Support Association, in their Treatments section.
3. Here is a page that is available to the public via a Norwegian University, from July 2011 (wow that is old!!) Rituximab as Second Line Treatment for ITP.
I am very keen to learn all I can about this clinical trial and possibly a readily available drug therapy. If anyone has been through the trial or a treatment program using Rituximab than please let us know how you went.
Look forward to hearing from you.